As 2024 draws to a close, Archbow Consulting reflects on a year of dynamic change within the pharmaceutical industry.
BLOG
Logistics Reimagined: The Benefits of Using a Virtual 3PL Vendor
As the world becomes increasingly digitized, a novel idea of a virtual third-party logistics (3PL) vendor has been established in the pharmaceutical industry.
Keep Your Planning in the Driver’s Seat: Review Your 2025 Patient Services Strategy Now
Navigate the open road ahead with confidence. Start planning today and ensure your 2025 program delivers the support your patients need.
Pre-Asembia Checklist for Market Access Teams
Pre-Asembia Checklist for Market Access Teams
A First-Hand Account of 3PLs – A Podcast on Distribution Best Practices
A First-Hand Account of 3PLs – A Podcast on Distribution Best Practices
Essential Takeaways from the 2024 ECRM Conference
Essential Takeaways from the 2024 ECRM Conference
Revving Up for 2024: Market Access Kick-Start Resources
Revving Up for 2024: Market Access Kick-Start Resources
Don’t Let Your Pharma Program Fall Behind – Optimize It Now
Don’t Let Your Pharma Program Fall Behind – Optimize It Now
Are Alternative Distribution Models a Viable Option for Pharma?
As seen in Pharmaceutical Commerce: Key considerations for drug manufacturers pursuing an effective alternative distribution model
Good vs. Excellent: How to Maximize Your 3PL Partnership
Good vs. Excellent: How to Maximize Your 3PL Partnership
3PL Health Checks Generate Savings for Manufacturers: Here’s How to Begin
3PL Health Checks Generate Savings for Manufacturers: Here’s How to Begin
Essential Takeaways from the 2023 ECRM Conference
Essential Program Takeaways from the 2023 ECRM Conference
10 Market Access Trends to Watch for in 2023
Our experts teamed up with Pharmaceutical Executive to identify 10 Market Access Trends to Watch for in 2023, spanning patients, prescribers
How Effective Product Distribution Strategies Maximize the Pharmaceutical Supply Chain
How pharmaceutical manufacturers can efficiently and effectively get product into the hands of patients
Webinar Archive: 11 Market Access Questions to Address Prior to Launching Your First Specialty Drug
Webinar Archive: Get answers to the eleven key questions that will help guide commercial teams in effectively launching specialty products.
Best Practices for Improving Program Performance Through Well-Managed SP Relationships
With a carefully crafted approach, SPs & Manufacturers can enjoy partnerships that drive access, adherence, and overall program performance
Control vs. Access: Why Clinical Characteristics Should Guide Specialty Pharmacy Strategy
When it comes to pharmacy network design, there is a careful balance between access and control.
How Equitable is Your Pharmacy Dispensing Strategy?
Pharmacy dispensing network strategies are an essential linchpin in any product’s commercial success.
How to Prepare for DSCSA D-Day
For manufacturers who haven’t started preparing for DSCSA D-Day, the “OH NO!” moment is here, but this article can help.
Effective and Practical Ways to Impact Health Inequity Now
Practical lists of questions spanning distribution, access, and affordability that market access teams can use to impact health equity today
11 Market Access Questions to Address Prior to Launching Your First Specialty Drug
The answers to these eleven questions will help guide commercial teams in effectively launching specialty products.
Maximizing Specialty Pharmacy Contracts
When approached strategically, contracting with SP networks can positively impact patient experience and the company’s bottom line.
9 Considerations When Designing Your Specialty Pharmacy Network
A proven, reliable methodology for designing a specialty pharmacy network is essential to ensuring optimal patient access